Drugs in development for toxoplasmosis: advances, challenges, and current status.

Drugs in development for toxoplasmosis: advances, challenges, and current status.

Item
http://www.wikidata.org/entity/Q37613765
The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug design.Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives.Dissection of the in vitro developmental program of Hammondia hammondi reveals a link between stress sensitivity and life cycle flexibility in Toxoplasma gondii.Acute Seronegative Toxoplasma gondii Hepatitis Allergic to First-Line Treatment.Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic ToxoplasmosisImmune Responses Induced by HSP60 DNA Vaccine against Toxoplasma gondii Infection in Kunming MiceImmunization with plasmid DNA expressing Heat Shock Protein 40 confers prophylactic protection against chronic Toxoplasma gondii infection in Kunming miceA Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for ToxoplasmosisHigh-content imaging assay to evaluate Toxoplasma gondii infection and proliferation: A multiparametric assay to screen new compoundsDrug Resistance inMicromanaging Immunity in the Murine Host vs. the Mosquito Vector: Microbiota-Dependent Immune Responses to Intestinal ParasitesA Window to EgressA Lactate Fermentation Mutant of Stimulates Protective Immunity Against Acute and Chronic Toxoplasmosis
P2860

Drugs in development for toxoplasmosis: advances, challenges, and current status.

Item
http://www.wikidata.org/entity/Q37613765
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@en
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@nl
type
label
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@en
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@nl
prefLabel
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@en
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@nl
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P407
P478
P5008
P577
P698
P921
P932
P356
P1433
P1476
Drugs in development for toxoplasmosis: advances, challenges, and current status.
@en
P2093
P275
P2860
P304
P31
P356
P407
P478
P5008
P577
P698
P921
P932